Aptevo Therapeutics (APVO) Short term Debt (2015 - 2022)
Aptevo Therapeutics (APVO) posted Short term Debt of $2.0 million for Q4 2022, little changed sequentially from $2.0 million in Q3 2022, and down 82.86% YoY from $11.7 million in Q4 2021.
Aptevo Therapeutics (APVO) Short term Debt (2015 - 2022) Analysis & Trends
Aptevo Therapeutics has reported Short term Debt for 8 years, with the latest figure at $2.0 million in Q4 2022.
- Quarterly Short term Debt fell 82.86% year-over-year to $2.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $2.0 million (down 82.86% YoY) and the FY2022 annual result came in at $2.0 million, down 82.86% from the prior year.
- Short term Debt held at $2.0 million in Q4 2022 per APVO's latest filing, from $2.0 million in the prior quarter.
- Over five years, Short term Debt peaked at $19.9 million in Q4 2019 and troughed at $2.0 million in Q1 2022.
- A 5-year average of $8.1 million and a median of $5.3 million in 2018 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2021 and 2022: Short term Debt soared 133.34% in 2021, then plunged 82.86% in 2022.
- Over 5 years, Short term Debt stood at $4.2 million in 2018, then soared by 376.67% to $19.9 million in 2019, then slumped by 74.83% to $5.0 million in 2020, then jumped by 133.34% to $11.7 million in 2021, then slumped by 82.86% to $2.0 million in 2022.
- According to Business Quant data, Short term Debt over the past three periods registered $2.0 million, $2.0 million, and $2.0 million for Q4 2022, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Aptevo Therapeutics | 3.30 Mn | -6.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 11.67 Mn |
| Sep 30, 2021 | 11.17 Mn |
| Jun 30, 2021 | 10.67 Mn |
| Mar 31, 2021 | 10.17 Mn |
| Dec 31, 2020 | 5.00 Mn |
| Dec 31, 2019 | 19.86 Mn |
| Sep 30, 2019 | 19.71 Mn |
| Jun 30, 2018 | 4.17 Mn |
| Mar 31, 2018 | 5.33 Mn |
| Dec 31, 2017 | 3.33 Mn |
| Sep 30, 2016 | 183,000.00 |
| Jun 30, 2016 | 191,000.00 |
| Dec 31, 2015 | 444,000.00 |